Prescient Therapeutics Ltd (PTX) — Cash Flow Quality Index

Latest as of June 2013: 0.07x

Prescient Therapeutics Ltd (PTX) has a Cash Flow Quality Index of 0.07x as of June 2013. Operating cash flow of AU$32.65K is below net income of AU$446.75K, suggesting accrual-heavy earnings not yet converted to cash. Also explore PTX total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

0.07x
Operating CF / Net Income

Operating Cash Flow

AU$32.65K
AUD

Net Income

AU$446.75K
AUD

Data as of

Jun 2013
Most recent filing

Prescient Therapeutics Ltd Cash Flow Quality Index (2013–2013)

Historical Cash Flow Quality Index for Prescient Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Prescient Therapeutics Ltd (2013–2013)

Year-by-year earnings quality comparison for Prescient Therapeutics Ltd. For live market cap and the full company financial profile, see PTX market cap overview.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2013 -0.02x AU$-29.18K AU$1.79 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.